Status:
RECRUITING
A Non-pharmacological Cough Control Therapy
Lead Sponsor:
West Park Healthcare Centre
Collaborating Sponsors:
St. Joseph's Healthcare Hamilton
Conditions:
Cough
ILD
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Coughing affects almost all individuals with ILD leading to physical, psychological and social distress and prevents individuals from performing their activities of daily living, working or socialisin...
Detailed Description
Research questions and hypotheses i) Is a non-pharmacological cough control therapy feasible to treat chronic cough in patients with ILD? Hypothesis: Given the results of previous non-pharmacological...
Eligibility Criteria
Inclusion
- Individuals will be included if having confirmed diagnosis of any ILD by a physician (as per Canadian Thoracic Society's guideline for evaluating patients with fibrotic interstitial lung disease) and a chronic cough lasting more than 8 weeks in duration
Exclusion
- self-reports of moderate or large sputum production
- effective or suspected exacerbation of the respiratory condition in the past month
- upper respiratory tract infection in the past month
- use of angiotensin-converting enzyme inhibitor medication
- changes in the prescribed medication in the previous month
- evidence of traction bronchiectasis in the HRCT
- evidence of other medical conditions that prevent performance of an exercise training program
- unable to read or speak in English / unable to provide informed consent.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04767074
Start Date
September 1 2020
End Date
December 1 2025
Last Update
April 3 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
2
West Park Healthcare Centre
Toronto, Ontario, Canada, M6M 2J5